NO170086C - Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener

Info

Publication number
NO170086C
NO170086C NO882335A NO882335A NO170086C NO 170086 C NO170086 C NO 170086C NO 882335 A NO882335 A NO 882335A NO 882335 A NO882335 A NO 882335A NO 170086 C NO170086 C NO 170086C
Authority
NO
Norway
Prior art keywords
tetrahydrotiophenes
tetrahydrofuranes
acyloxymethyl
ammonio
omega
Prior art date
Application number
NO882335A
Other languages
English (en)
Norwegian (no)
Other versions
NO170086B (no
NO882335L (no
NO882335D0 (no
Inventor
Jean-Jacques Godfroid
Francoise Heymans
Pierre Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO882335D0 publication Critical patent/NO882335D0/no
Publication of NO882335L publication Critical patent/NO882335L/no
Publication of NO170086B publication Critical patent/NO170086B/no
Publication of NO170086C publication Critical patent/NO170086C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO882335A 1987-05-29 1988-05-27 Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener NO170086C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (4)

Publication Number Publication Date
NO882335D0 NO882335D0 (no) 1988-05-27
NO882335L NO882335L (no) 1988-11-30
NO170086B NO170086B (no) 1992-06-01
NO170086C true NO170086C (no) 1992-09-09

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882335A NO170086C (no) 1987-05-29 1988-05-27 Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener

Country Status (32)

Country Link
US (1) US5017588A (fr)
JP (1) JPH0631228B2 (fr)
KR (1) KR960005152B1 (fr)
AR (1) AR243885A1 (fr)
AT (1) AT395715B (fr)
AU (1) AU610789B2 (fr)
BE (1) BE1002146A3 (fr)
CA (1) CA1317959C (fr)
CH (1) CH674985A5 (fr)
DE (1) DE3818106A1 (fr)
DK (1) DK167532B1 (fr)
ES (1) ES2009924A6 (fr)
FI (1) FI89353C (fr)
FR (2) FR2615735B1 (fr)
GB (2) GB8712693D0 (fr)
GR (1) GR1000147B (fr)
HK (1) HK101790A (fr)
IE (1) IE61341B1 (fr)
IN (1) IN168799B (fr)
IT (1) IT1219698B (fr)
LU (1) LU87229A1 (fr)
MA (1) MA21289A1 (fr)
MY (1) MY103289A (fr)
NL (1) NL192203C (fr)
NO (1) NO170086C (fr)
NZ (1) NZ224775A (fr)
OA (1) OA08878A (fr)
PT (1) PT87585B (fr)
SE (1) SE466449B (fr)
SG (1) SG93790G (fr)
TN (1) TNSN88049A1 (fr)
ZA (1) ZA883731B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
FI882475A (fi) 1988-11-30
MA21289A1 (fr) 1988-12-31
AR243885A1 (es) 1993-09-30
FR2615854B1 (fr) 1990-12-28
HK101790A (en) 1990-12-14
GR1000147B (el) 1991-09-27
GR880100342A (en) 1989-02-23
PT87585B (pt) 1992-09-30
SE8801964D0 (sv) 1988-05-26
ZA883731B (en) 1989-02-22
FR2615735B1 (fr) 1991-01-11
FR2615735A1 (fr) 1988-12-02
DE3818106C2 (fr) 1993-07-01
AU610789B2 (en) 1991-05-23
OA08878A (fr) 1989-10-31
SG93790G (en) 1991-01-18
ES2009924A6 (es) 1989-10-16
NO170086B (no) 1992-06-01
NL192203C (nl) 1997-03-04
AT395715B (de) 1993-02-25
NL192203B (nl) 1996-11-01
PT87585A (pt) 1989-05-31
IE61341B1 (en) 1994-11-02
BE1002146A3 (fr) 1990-07-31
GB2205100B (en) 1990-08-15
CH674985A5 (fr) 1990-08-15
CA1317959C (fr) 1993-05-18
JPH0631228B2 (ja) 1994-04-27
AU1672288A (en) 1988-12-01
NO882335L (no) 1988-11-30
GB8812488D0 (en) 1988-06-29
MY103289A (en) 1993-05-29
SE466449B (sv) 1992-02-17
ATA140788A (de) 1992-07-15
DK291088D0 (da) 1988-05-27
DK167532B1 (da) 1993-11-15
US5017588A (en) 1991-05-21
LU87229A1 (fr) 1988-12-13
FI882475A0 (fi) 1988-05-26
IN168799B (fr) 1991-06-08
FR2615854A1 (fr) 1988-12-02
DE3818106A1 (de) 1988-12-15
GB2205100A (en) 1988-11-30
JPS649988A (en) 1989-01-13
NO882335D0 (no) 1988-05-27
NZ224775A (en) 1990-01-29
IT8820773A0 (it) 1988-05-27
IT1219698B (it) 1990-05-24
KR880013928A (ko) 1988-12-22
FI89353B (fi) 1993-06-15
GB8712693D0 (en) 1987-07-01
SE8801964L (sv) 1988-11-30
NL8801315A (nl) 1988-12-16
IE881599L (en) 1988-11-29
DK291088A (da) 1988-11-30
FI89353C (fi) 1993-09-27
TNSN88049A1 (fr) 1990-07-10
KR960005152B1 (ko) 1996-04-22

Similar Documents

Publication Publication Date Title
NO169439C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO170727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater
NO172048C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoler
NO164977C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske substituert-fenoksyalkylisoksazoler og -furaner.
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO172849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater
NO171679C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(1-piperazinyl)-1h-indazoler
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO884175D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO170086C (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO168359C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere
NO172538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-fenoksymetyl-4-hydroksytetrahydropyran-2-oner og 6-tiofen-oksymetyl-4-hydroksytetrahydropyran-2-oner
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002